APP and Alzheimer disease: Our previous study showed that dl‐PHPB could upregulate PI3K/Akt signaling pathway and downregulated the expression of phosphorylated GSK‐3β in APP and presenilin 1 (PS1) double‐transgenic (APP/PS1) AD mice and further reduced hyperphosphorylation of tau protein.14